Teladoc Health (NYSE:TDOC - Get Free Report) had its price objective decreased by Bank of America from $9.50 to $8.00 in a report released on Friday,Benzinga reports. The firm currently has a "neutral" rating on the health services provider's stock. Bank of America's price target would suggest a potential upside of 10.34% from the company's current price.
A number of other research analysts have also issued reports on the company. Royal Bank of Canada boosted their price target on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Oppenheimer decreased their target price on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research report on Friday, January 24th. The Goldman Sachs Group reduced their price target on shares of Teladoc Health from $16.00 to $13.00 and set a "buy" rating for the company in a research note on Monday, March 3rd. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a research note on Thursday, February 27th. Finally, Piper Sandler dropped their target price on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. Eleven research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $10.94.
Get Our Latest Stock Report on TDOC
Teladoc Health Price Performance
NYSE:TDOC remained flat at $7.25 during midday trading on Friday. The company had a trading volume of 3,327,989 shares, compared to its average volume of 6,242,107. The stock has a market capitalization of $1.27 billion, a price-to-earnings ratio of -1.26 and a beta of 1.73. The firm has a fifty day moving average of $9.66 and a two-hundred day moving average of $9.70. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health has a twelve month low of $6.61 and a twelve month high of $15.21.
Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. On average, equities research analysts forecast that Teladoc Health will post -1.16 earnings per share for the current fiscal year.
Insider Activity
In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. This trade represents a 14.62 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.95% of the stock is owned by company insiders.
Institutional Trading of Teladoc Health
A number of hedge funds have recently made changes to their positions in TDOC. Versant Capital Management Inc increased its stake in Teladoc Health by 313.8% in the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock valued at $29,000 after buying an additional 2,441 shares during the period. Whipplewood Advisors LLC acquired a new position in shares of Teladoc Health in the fourth quarter worth $29,000. Lindbrook Capital LLC increased its stake in shares of Teladoc Health by 78.9% in the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after acquiring an additional 1,612 shares during the last quarter. Sterling Capital Management LLC raised its holdings in shares of Teladoc Health by 776.7% during the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock worth $42,000 after acquiring an additional 4,101 shares in the last quarter. Finally, Pilgrim Partners Asia Pte Ltd purchased a new position in Teladoc Health in the fourth quarter valued at about $60,000. 76.82% of the stock is owned by hedge funds and other institutional investors.
Teladoc Health Company Profile
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
